SJS Investment Consulting’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $127 | Sell |
4
-2
| -33% | -$64 | ﹤0.01% | 1452 |
|
|
2025
Q1 | $200 | Hold |
6
| – | – | ﹤0.01% | 1449 |
|
|
2024
Q4 | $207 | Sell |
6
-2
| -25% | -$69 | ﹤0.01% | 1457 |
|
|
2024
Q3 | $320 | Buy |
8
+3
| +60% | +$120 | ﹤0.01% | 1434 |
|
|
2024
Q2 | $151 | Buy |
5
+2
| +67% | +$60 | ﹤0.01% | 1548 |
|
|
2024
Q1 | $101 | Sell |
3
-1
| -25% | -$34 | ﹤0.01% | 1566 |
|
|
2023
Q4 | $130 | Sell |
4
-3
| -43% | -$98 | ﹤0.01% | 1522 |
|
|
2023
Q3 | $230 | Hold |
7
| – | – | ﹤0.01% | 1432 |
|
|
2023
Q2 | $247 | Buy |
7
+6
| +600% | +$212 | ﹤0.01% | 1364 |
|
|
2023
Q1 | $33 | Sell |
1
-8
| -89% | -$264 | ﹤0.01% | 1545 |
|
|
2022
Q4 | $496 | Buy |
9
+5
| +125% | +$276 | ﹤0.01% | 1220 |
|
|
2022
Q3 | $0 | Buy |
+4
| New | – | ﹤0.01% | 1255 |
|
|
2022
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 986 |
|